LATEST NEWS
EN 14476: Chemical disinfectants and antiseptics standard
Perfectus Biomed Group, Magnitude Biosciences, and University of Kent Project Funded by National Biofilms Innovation Centre for Tackling and Exploiting Biofilms
A joint project for Perfectus Biomed Group, Magnitude Biosciences, and the University of Kent aims to provide an assay to aid research on infections caused by Pseudomonas aeruginosa, delivering a solution to accelerate wound care research and reduce the reliance on...
Accredited ex vivo Lung Model Biofilm Testing
Biofilm Awareness Week
Perfectus Biomed Group are excited to support The National Biofilms Innovation Centre (NBIC) #BiofilmWeek, highlighting the research taking place to prevent, detect, manage, and engineer biofilms. Perfectus Biomed’s mission is to harness...
A wounded ex vivo human skin model to study microbial biofilm development and anti-biofilm therapeutics.
Perfectus Biomed Group have an actively innovative culture, and we strive to practice science that improves lives. Our unique specialism in biofilms, and our experience in customisable tissue models built the base for this particularly interesting study.
Biofilm forming...
Cell Line Quality Control and Authentication – Are your cells what you think they are?
Do you always know what cell line you are working with? I am sure most of you reading this right now are nodding, confident in your cell line quality control, however there is a widely unknown reproducibility crisis that is threatening viral and mycobacterium contamination...
Perfectus Biomed Group Publish Paper – The Antimicrobial Potential of Cannabidiol
Perfectus Biomed Group are leading the market with accredited biofilm test methods, and research & development. Our team in the US collaborated on a paper published in Communications Biology, that explored the antimicrobial potential of cannabidiol. The...
A Sweet Collaboration – Perfectus Biomed and SweetBio publish joint paper
Perfectus Biomed Group and SweetBio Inc. have published a joint paper in Biomedical and Translational Science exploring the activity and efficiency of a novel bioengineered wound product (BWP) and its potential to help combat infection. Perfectus Biomed regularly...
UKAS ISO 17025 accredited Single Tube Method for Determining the Efficacy of Disinfectants against Candida albicans Biofilm
Perfectus Biomed Group are excited to announce that we have recently received UKAS 17025 accreditation for the extension to scope for the Single Tube Method to include Candida albicans as a test organism. We are industry leaders in biofilm testing methods, please contact...
Perfectus Biomed work with the FDA to develop an ex vivo pig skin model of IV catheter related infection
Perfectus Biomed are experts in developing ‘fit for purpose’ experiments to mimic real life scenarios. In partnership with the FDA, Perfectus Biomed have developed and published in Nature, the first ex-vivo porcine skin-catheter model and accompanying test methods...